Metraipolis › archive › dc_dee33c4f5eab

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology) — Europe PMC PMID:41012496

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012496
DOI
10.3390/pharmaceutics17091159
License (as archived)
solo-consultazione
Archived
2026-11-10T04:01:27.321Z
SHA-256 of the archived text
a93763a8f2f9903a850f5ff2d2dde00f9a977049259ed9e7c353c293e3a5ca45
Stable URL of this page
https://metraipolis.com/documento/dc_dee33c4f5eab

How to cite

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology) — Europe PMC PMID:41012496 — Europe PMC (en), https://europepmc.org/article/MED/41012496 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dee33c4f5eab (Metraipolis archive dc_dee33c4f5eab, sha256 a93763a8f2f9903a850f5ff2d2dde00f9a977049259ed9e7c353c293e3a5ca45)
BibTeX
@misc{dcdee33c4f5eab,
  title = {Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology) — Europe PMC PMID:41012496},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012496},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dee33c4f5eab; sha256 a93763a8f2f9903a850f5ff2d2dde00f9a977049259ed9e7c353c293e3a5ca45},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012496. Agents can read the archived copy with the MCP tool read_document.